文献速递肝病

基于机器学习的NAFLD活检组织脂肪变、炎症、气球样变和纤维化高通量定量分析

High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-12-27

软件定量脂肪、炎症、气球样变和纤维化百分比及胶原比例面积,与病理学家标注一致性高,并在验证队列中确认。

要点

  • 机器学习软件可自动定量NAFLD活检的脂肪变、炎症、气球样变和纤维化。
  • 软件与病理学家标注的组内相关系数在0.92至0.97之间。
  • 软件观察者间与观察者内一致性为0.95至0.99,高于半定量评分系统的0.58至0.88。

核心结论

  • 机器学习软件可快速、客观分析NAFLD活检组织学特征,结果与肝胆病理学家标注相关且一致性好,并在独立患者队列中验证。
  • 该工具可能用于临床实践和临床试验中客观评估NAFLD治疗反应。

研究设计与样本

  • 前100例活检标本用于推导算法,随后146例用于验证。
  • 活检标本由病理学家按NASH临床研究网络(NASH CRN)标准独立评分并数字化,由2名肝胆病理学家标注区域供机器学习。

主要发现

  • 推导组中手工标注与软件结果的组内相关系数(ICC):脂肪变为0.97(95%CI 0.95-0.99;P<.001)。
  • 推导组ICC:炎症为0.96(95%CI 0.9-0.98;P<.001),气球样变为0.94(95%CI 0.87-0.98;P<.001)。
  • 推导组纤维化ICC为0.92(95%CI 0.88-0.96;P=.001);推导组脂肪、炎症、气球样变百分比及胶原比例面积在验证队列中得到确认。
  • 软件识别NAFLD组织学特征的观察者间与观察者内一致性为0.95至0.99,高于半定量评分系统的0.58至0.88。
  • 在配对肝活检亚组中,定量分析较NASH CRN评分系统更敏感地检测差异。

临床怎么用

  • 可考虑用该自动化软件对NAFLD活检进行客观定量,辅助评估组织学特征及治疗前后变化。
  • 软件定量结果与病理学家标注一致性高,但用于临床决策前仍需结合病理医师判读。

局限性

  • 研究为单中心连续患者队列,推导与验证样本分别来自前100例和后146例。
  • 原文未报告软件对临床结局的预测价值及在常规病理流程中的可行性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Liver biopsy is the reference standard for staging and grading nonalcoholic fatty liver disease (NAFLD), but histologic scoring systems are semiquantitative with marked interobserver and intraobserver variation. We used machine learning to develop fully automated software for quantification of steatosis, inflammation, ballooning, and fibrosis in biopsy specimens from patients with NAFLD and validated the technology in a separate group of patients. METHODS: We collected data from 246 consecutive patients with biopsy-proven NAFLD and followed up in London from January 2010 through December 2016. Biopsy specimens from the first 100 patients were used to derive the algorithm and biopsy specimens from the following 146 were used to validate it. Biopsy specimens were scored independently by pathologists using the Nonalcoholic Steatohepatitis Clinical Research Network criteria and digitalized. Areas of steatosis, inflammation, ballooning, and fibrosis were annotated on biopsy specimens by 2 hepatobiliary histopathologists to facilitate machine learning. Images of biopsies from the derivation and validation sets then were analyzed by the algorithm to compute percentages of fat, inflammation, ballooning, and fibrosis, as well as the collagen proportionate area, and compared with findings from pathologists' manual annotations and conventional scoring systems. RESULTS: In the derivation group, results from manual annotation and the software had an interclass correlation coefficient (ICC) of 0.97 for steatosis (95% CI, 0.95-0.99; P < .001); ICC of 0.96 for inflammation (95% CI, 0.9-0.98; P < .001); ICC of 0.94 for ballooning (95% CI, 0.87-0.98; P < .001); and ICC of 0.92 for fibrosis (95% CI, 0.88-0.96; P = .001). Percentages of fat, inflammation, ballooning, and the collagen proportionate area from the derivation group were confirmed in the validation cohort. The software identified histologic features of NAFLD with levels of interobserver and intraobserver agreement ranging from 0.95 to 0.99; this value was higher than that of semiquantitative scoring systems, which ranged from 0.58 to 0.88. In a subgroup of paired liver biopsy specimens, quantitative analysis was more sensitive in detecting differences compared with the nonalcoholic steatohepatitis Clinical Research Network scoring system. CONCLUSIONS: We used machine learning to develop software to rapidly and objectively analyze liver biopsy specimens for histologic features of NAFLD. The results from the software correlate with those from histopathologists, with high levels of interobserver and intraobserver agreement. Findings were validated in a separate group of patients. This tool might be used for objective assessment of response to therapy for NAFLD in practice and clinical trials.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Forlano R, Mullish BH, Giannakeas N, et al. High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019. PMID: 31887451. doi:10.1016/j.cgh.2019.12.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。